Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Classical hematology 1

Conditions

Anemia 3Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Fatigue 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1

Interventions

Therapeutics 4Counseling 2exemestane 1Triptorelin Pamoate 1Taxes 1Tamoxifen 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Polymerase Chain Reaction 1Paclitaxel 1Microarray Analysis 1Methylphenidate 1Metformin 1Mental Status and Dementia Tests 1Interviews as Topic 1Gonadotropin-Releasing Hormone 1Gene Expression Profiling 1Exercise Test 1Epoetin Alfa 1Enzyme-Linked Immunosorbent Assay 1Early Intervention, Educational 1Dexamethasone 1Carnitine 1Carboplatin 1Brachytherapy 1Analgesia 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Fatigue × Epoetin Alfa × Clear all
NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
282 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡